Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281776257> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- W4281776257 abstract "<h3></h3> Awareness of overdiagnosis reality caused by mass screening is shifting our understanding of breast cancer and obliging us to make a complete paradigm shift. Overdiagnosis reveals a hidden world of breast cancer and opens up a much broader view of the natural history of the cancer disease. Reducing this disease to just a tumor’s histology and its radiological image is obsolete. Over-diagnosed cancers, as well as cancers in situ, are not a first stage. There are not necessarily successive stages that punctuate the disease until death. The disease can appear in an advanced form from the start. Metastases can inaugurate it. This explains why the search for an early diagnosis based on radiological size has led to failure and why advanced cancers have not regressed in number with screening, they have only been diluted by overdiagnosis. Overdiagnosis prompts new questions: When, how and where does progressive disease begin? What is the nature and function of the tumor? Does the tumor define the disease or is it only one element of an interaction with its environment? The time has come for new hypotheses. The disease would not develop like a tree that grows progressively and unidirectionally, but like a bush where interactions and retroactions could lead to the continuation of life as well as to death. The mutated cell or cells would orient themselves from the beginning towards different paths according to the resistances that are an obstacle to their survival. The Halstedian scheme of the natural history of the disease on which mass screening has been based is erroneous and makes screening a totally counterproductive public health operation. The growing debate on the benefits and risks of breast cancer screening in scientific, medical and public spheres, led the French Minister of Health to initiate a scientific and public consultation on breast cancer screening in 2015. The consultation conducted in France is the third independent consultation in Europe, after the British (2012) and the Swiss (2014) ones. All of them emphasized the need for complete and balanced information and recognized overdiagnosis as a serious harm. Despite the request of French citizens expressed in 2016, the promotion of organized screening continues unchanged, through the Pink October campaigns and incentive TV shows, lacking objective and independent information for women. Breast cancer screening continues to be part of the Remuneration on Public Health Objectives for physicians (ROSP). Pro-screening propaganda is intensifying in the midst of the Covid pandemic through the media. In September 2020, the INCA (National Cancer Institute) launches a new consultation for the decennial strategy to fight against cancer. One of the measures proposed is even to experiment with financial incentives for women to increase their participation in screening, which is stagnating at around 50%, far from the target of 70%. In this context and since its creation in 2015, the association Cancer Rose fights for an objective, fair and neutral information for women, to enable them to make an informed decision on whether or not to be screened." @default.
- W4281776257 created "2022-06-13" @default.
- W4281776257 creator A5018936439 @default.
- W4281776257 creator A5074843026 @default.
- W4281776257 date "2022-06-01" @default.
- W4281776257 modified "2023-09-30" @default.
- W4281776257 title "43 Breast cancer, another view of the disease. Towards a better information of women" @default.
- W4281776257 doi "https://doi.org/10.1136/bmjebm-2022-podabstracts.10" @default.
- W4281776257 hasPublicationYear "2022" @default.
- W4281776257 type Work @default.
- W4281776257 citedByCount "0" @default.
- W4281776257 crossrefType "proceedings-article" @default.
- W4281776257 hasAuthorship W4281776257A5018936439 @default.
- W4281776257 hasAuthorship W4281776257A5074843026 @default.
- W4281776257 hasConcept C121608353 @default.
- W4281776257 hasConcept C126322002 @default.
- W4281776257 hasConcept C142724271 @default.
- W4281776257 hasConcept C163276114 @default.
- W4281776257 hasConcept C177713679 @default.
- W4281776257 hasConcept C2779134260 @default.
- W4281776257 hasConcept C2779377019 @default.
- W4281776257 hasConcept C530470458 @default.
- W4281776257 hasConcept C71924100 @default.
- W4281776257 hasConceptScore W4281776257C121608353 @default.
- W4281776257 hasConceptScore W4281776257C126322002 @default.
- W4281776257 hasConceptScore W4281776257C142724271 @default.
- W4281776257 hasConceptScore W4281776257C163276114 @default.
- W4281776257 hasConceptScore W4281776257C177713679 @default.
- W4281776257 hasConceptScore W4281776257C2779134260 @default.
- W4281776257 hasConceptScore W4281776257C2779377019 @default.
- W4281776257 hasConceptScore W4281776257C530470458 @default.
- W4281776257 hasConceptScore W4281776257C71924100 @default.
- W4281776257 hasLocation W42817762571 @default.
- W4281776257 hasOpenAccess W4281776257 @default.
- W4281776257 hasPrimaryLocation W42817762571 @default.
- W4281776257 hasRelatedWork W1589844 @default.
- W4281776257 hasRelatedWork W17338368 @default.
- W4281776257 hasRelatedWork W17784622 @default.
- W4281776257 hasRelatedWork W17957631 @default.
- W4281776257 hasRelatedWork W18557889 @default.
- W4281776257 hasRelatedWork W21296561 @default.
- W4281776257 hasRelatedWork W21842780 @default.
- W4281776257 hasRelatedWork W3498247 @default.
- W4281776257 hasRelatedWork W7038429 @default.
- W4281776257 hasRelatedWork W9360235 @default.
- W4281776257 isParatext "false" @default.
- W4281776257 isRetracted "false" @default.
- W4281776257 workType "article" @default.